Anthony Chikere
Sangamo Therapeutics
First time coming to the CGT to talk. Totally enjoyed the content, the interaction with, you know, different companies. The talks were very relevant to what we’re doing currently.
Brian Tomkowicz
SK pharmteco
“Highly focused good participation around what 100 people a lot of good science being presented innovation companies manufacturing companies and other novel technologies RNA and and IPSC’s”
Connect directly with qualified decision-makers through speaking opportunities, curated meetings, and high-value networking!